前收市價 | 2.2500 |
開市 | 2.1000 |
買盤 | 0.0000 |
賣出價 | 2.5000 |
拍板 | 530.00 |
到期日 | 2024-07-05 |
今日波幅 | 1.9400 - 2.3000 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 11 |
While CF remains the main area of focus, Vertex (VRTX) has seen rapid success in its non-CF pipeline candidates' development in the past year.
The biotech's shares have traded sideways for over a year, but better days could be on the near-term horizon.
Vertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.